{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:21:27Z","timestamp":1791901287953,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Arjuna Natural Extracts Limited"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.euroneuro.2014.11.015","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T01:00:34Z","timestamp":1417827634000},"page":"38-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change"],"prefix":"10.1016","volume":"25","author":[{"given":"Adrian L.","family":"Lopresti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.M.","family":"Meddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth L.","family":"Maker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Arnoldussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.npep.2009.12.014","article-title":"Pathogenic involvement of neuropeptides in anxiety and depression","volume":"44","author":"Alldredge","year":"2010","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.euroneuro.2014.11.015_bib2","first-page":"337","article-title":"Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients","volume":"15","author":"Belcaro","year":"2010","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.euroneuro.2014.11.015_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psyneuen.2013.12.004","article-title":"HPA axis and aging in depression: systematic review and meta-analysis","volume":"41C","author":"Belvederi Murri","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/WNF.0b013e31828ef969","article-title":"Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study","volume":"36","author":"Bergman","year":"2013","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib6","first-page":"208","article-title":"Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant\/anxiolytic response","volume":"29","author":"Blier","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.11.015_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PSY.0b013e3181fdfb25","article-title":"Depression predicts elevated endothelin-1 in patients with coronary artery disease","volume":"73","author":"Burg","year":"2011","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.euroneuro.2014.11.015_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","article-title":"Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial","volume":"25","author":"Chuengsamarn","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","article-title":"The role of substance P in stress and anxiety responses","volume":"31","author":"Ebner","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.euroneuro.2014.11.015_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-3-27","article-title":"Differential effects of curcumin on vasoactive factors in the diabetic rat heart","volume":"3","author":"Farhangkhoee","year":"2006","journal-title":"Nutr. Metab."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1734-1140(09)70084-2","article-title":"Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment","volume":"61","author":"Galecki","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.euroneuro.2014.11.015_bib12","first-page":"487","article-title":"Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis","volume":"25","author":"Giordano","year":"2011","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"2","key":"10.1016\/j.euroneuro.2014.11.015_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S1461145711000368","article-title":"Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder","volume":"15","author":"Hlavacova","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8678\u20138679","key":"10.1016\/j.euroneuro.2014.11.015_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(89)92955-3","article-title":"Endothelin concentrations in cerebrospinal fluid in depressive patients","volume":"2","author":"Hoffman","year":"1989","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.euroneuro.2014.11.015_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.euroneuro.2014.11.015_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/ajp.144.2.229","article-title":"Blunted aldosterone and ACTH release after human CRH administration in depressed patients","volume":"144","author":"Holsboer","year":"1987","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2014.11.015_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"issue":"9","key":"10.1016\/j.euroneuro.2014.11.015_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1139\/y2012-059","article-title":"Attenuation of endothelin-1-induced PKB and ERK1\/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells","volume":"90","author":"Kapakos","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2014.11.015_bib19","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cellsig.2010.05.002","article-title":"Endothelin\u2014biology and disease","volume":"22","author":"Khimji","year":"2010","journal-title":"Cell Signal."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.11.015_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-2000-8132","article-title":"Comparison of the effects of endothelin-1 and -3 on secretion of pituitary hormones in healthy male volunteers","volume":"108","author":"Kiefer","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"18\u201319","key":"10.1016\/j.euroneuro.2014.11.015_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.lfs.2013.09.014","article-title":"Low doses of curcumin protect alcohol-induced liver damage by modulation of the alcohol metabolic pathway, CYP2E1 and AMPK","volume":"93","author":"Lee","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2014.11.015_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.euroneuro.2014.11.015_bib23","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1177\/0269881112458732","article-title":"Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects","volume":"26","author":"Lopresti","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.11.015_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","article-title":"Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study","volume":"167","author":"Lopresti","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2014.11.015_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","article-title":"A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers","volume":"48","author":"Lopresti","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2014.11.015_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.coph.2007.10.010","article-title":"The leptin hypothesis of depression: a potential link between mood disorders and obesity?","volume":"7","author":"Lu","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.11.015_bib27","first-page":"117","article-title":"The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuroendocrinology Lett."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.11.015_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1600-0447.2012.01908.x","article-title":"In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes","volume":"127","author":"Maes","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.euroneuro.2014.11.015_bib29","first-page":"715","article-title":"Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"30","author":"Maes","year":"2009","journal-title":"Neuroendocrinol. Lett."},{"issue":"2","key":"10.1016\/j.euroneuro.2014.11.015_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2012.09.032","article-title":"The DEX\/CRH test for major depression: a potentially useful diagnostic test","volume":"208","author":"Mokhtari","year":"2013","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.11.015_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nn1454","article-title":"Molecular and anatomical determinants of central leptin resistance","volume":"8","author":"Munzberg","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"1-3","key":"10.1016\/j.euroneuro.2014.11.015_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(03)01629-7","article-title":"Role of brain thromboxane A2 in the release of noradrenaline and adrenaline from adrenal medulla in rats","volume":"467","author":"Okada","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.euroneuro.2014.11.015_bib33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ptr.5149","article-title":"Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial","volume":"28","author":"Panahi","year":"2014","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.euroneuro.2014.11.015_bib34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1017\/S0007114511006544","article-title":"Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial","volume":"108","author":"Panahi","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00000441-199403000-00011","article-title":"High plasma concentrations of cortisol and thromboxane B2 in patients with depression","volume":"307","author":"Piccirillo","year":"1994","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.11.015_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1734-1140(10)70240-1","article-title":"Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress","volume":"62","author":"Piechota","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.euroneuro.2014.11.015_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2013.12.018","article-title":"Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice","volume":"560","author":"Pinho-Ribeiro","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.11.015_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2014.11.015_bib39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ptr.5025","article-title":"Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial","volume":"28","author":"Sanmukhani","year":"2014","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.euroneuro.2014.11.015_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/092986706776055652","article-title":"Pharmacology and physiopathology of the brain endothelin system: an overview","volume":"13","author":"Schinelli","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.11.015_bib41","doi-asserted-by":"crossref","first-page":"H1978","DOI":"10.1152\/ajpheart.01318.2007","article-title":"Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure","volume":"294","author":"Sellers","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.euroneuro.2014.11.015_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","article-title":"Platelet\/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.euroneuro.2014.11.015_bib43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0006-2952(99)00206-3","article-title":"Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling","volume":"58","author":"Shah","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. 20","key":"10.1016\/j.euroneuro.2014.11.015_bib44","first-page":"S22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2014.11.015_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0301-0082(99)00034-9","article-title":"Endothelin and dopamine release","volume":"60","author":"van den Buuse","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.euroneuro.2014.11.015_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12529-011-9190-5","article-title":"Lifetime history of depression, type 2 diabetes, and endothelial reactivity to acute stress in postmenopausal women","volume":"19","author":"Wagner","year":"2012","journal-title":"Int. J. Behav. Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.11.015_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00383-005-1599-y","article-title":"The role of nuclear factor-kappa B in bacterial translocation in cholestatic rats","volume":"22","author":"Weber-Mzell","year":"2006","journal-title":"Pediatr. Surg. Int."},{"issue":"10","key":"10.1016\/j.euroneuro.2014.11.015_bib48","first-page":"905","article-title":"Effects of qingyi II granules on intestinal bacterial translocation in rats with acute necrotizing pancreatitis","volume":"29","author":"Xiao","year":"2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"2","key":"10.1016\/j.euroneuro.2014.11.015_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11684-013-0263-5","article-title":"Leptin signaling and leptin resistance","volume":"7","author":"Zhou","year":"2013","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.11.015_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/PSY.0b013e31821a196f","article-title":"Leptin as a neuroactive agent","volume":"73","author":"Zupancic","year":"2011","journal-title":"Psychosom. Med."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T01:50:42Z","timestamp":1538013042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0924977X14003265"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.015","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}